Prime Medicine, Inc. (PRME)
3.67
-0.06
(-1.61%)
USD |
NASDAQ |
Oct 23, 16:00
3.60
-0.07
(-1.91%)
After-Hours: 20:00
Prime Medicine Price : 3.67 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3.70 | 3.70 | 3.38 | 3.67 | 4.563M |
| Oct 22, 2026 | 3.68 | 3.920 | 3.62 | 3.73 | 4.658M |
| Oct 21, 2026 | 3.92 | 4.005 | 3.795 | 3.81 | 2.439M |
| Oct 20, 2026 | 3.75 | 4.05 | 3.73 | 3.92 | 3.695M |
| Oct 19, 2026 | 3.56 | 3.87 | 3.49 | 3.83 | 4.250M |
| Oct 16, 2026 | 3.55 | 3.605 | 3.41 | 3.47 | 4.393M |
| Oct 15, 2026 | 3.12 | 3.65 | 3.06 | 3.61 | 6.300M |
| Oct 14, 2026 | 3.21 | 3.22 | 3.045 | 3.13 | 4.237M |
| Oct 13, 2026 | 3.61 | 3.61 | 3.27 | 3.32 | 4.065M |
| Oct 12, 2026 | 3.95 | 3.965 | 3.58 | 3.61 | 3.138M |
| Oct 09, 2026 | 3.57 | 4.14 | 3.54 | 3.99 | 8.066M |
| Oct 08, 2026 | 3.83 | 3.898 | 3.52 | 3.58 | 7.726M |
| Oct 07, 2026 | 3.36 | 4.02 | 3.300 | 3.90 | 11.20M |
| Oct 06, 2026 | 3.56 | 3.718 | 3.26 | 3.50 | 12.02M |
| Oct 05, 2026 | 3.00 | 3.26 | 2.88 | 3.21 | 4.717M |
| Oct 02, 2026 | 3.05 | 3.075 | 2.92 | 2.98 | 2.110M |
| Oct 01, 2026 | 3.05 | 3.105 | 2.98 | 2.99 | 2.830M |
| Sep 30, 2026 | 3.11 | 3.19 | 3.02 | 3.055 | 3.132M |
| Sep 29, 2026 | 2.93 | 3.135 | 2.88 | 3.09 | 3.606M |
| Sep 28, 2026 | 2.85 | 2.92 | 2.77 | 2.875 | 3.682M |
| Sep 25, 2026 | 3.42 | 3.44 | 2.875 | 2.90 | 7.116M |
| Sep 24, 2026 | 3.11 | 3.13 | 2.990 | 3.07 | 4.485M |
| Sep 23, 2026 | 3.53 | 3.53 | 3.12 | 3.13 | 3.334M |
| Sep 22, 2026 | 3.22 | 3.565 | 3.20 | 3.54 | 2.725M |
| Sep 21, 2026 | 3.19 | 3.27 | 3.10 | 3.19 | 2.946M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 11.21 |
| Beam Therapeutics, Inc. | 24.05 |
| Twist Bioscience Corp. | 139.92 |
| Moderna, Inc. | 200.10 |
| Q32 Bio, Inc. | 8.65 |
Price Related Metrics
| PS Ratio | 156.63 |
| Price to Book Value | 16.66 |
| Earnings Yield | -29.58% |
| Market Cap | 663.31M |